Head-to-head · WeighScore
AVArx vs Harbor
The verdict
Harbor takes it — 72/100 to 55.9/100.
Harbor grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AVArx | Harbor |
|---|---|---|
| WeighScore | 55.9/100 | 72/100 |
| Grade | C | C |
| Scorecard rank | #426 | #86 |
| Semaglutide | Not disclosed | $99/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $149/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #426 · C
Strengths
- Publishes exactly which states require a live audio or video visit before a prescription, which almost no competitor discloses
- Names its prescribing group, Arora Health & Aesthetics, and gives a medical compliance contact
- Terms state service is available to residents of all 50 states, and the shipping policy matches
- Dates its own editorial reviews on treatment pages
- HSA/FSA accepted with receipts provided for reimbursement
Where it loses points
- No price is published anywhere on the site, on treatment pages or in the intake, so you cannot compare before starting a visit
- Never states whether its semaglutide and tirzepatide are compounded or brand-name
- No dispensing pharmacy is named, only licensed pharmacies in our network
- Cancellation terms are not published, only presented at checkout
- Prescriptions cannot be returned once dispensed, and the refund policy is otherwise unstated
Graded #86 · C
Strengths
- Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
- LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
- 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
- 12-Month Money Back Guarantee if you don't reach your weight-loss goal
- HSA/FSA eligible; no hidden fees, no insurance billed
Where it loses points
- Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
- Dietitian support offered only post-program (maintenance phase), not during active treatment
- State-specific consultation types vary; nationwide availability unconfirmed for all states
- No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
- Newer brand; success rate and member counts are on-site claims, not third-party verified
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.